Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration
- PMID: 19631603
- DOI: 10.1053/j.gastro.2009.03.064
Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration
Comment on
-
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.Gastroenterology. 2008 May;134(5):1352-9. doi: 10.1053/j.gastro.2008.02.024. Epub 2008 Feb 14. Gastroenterology. 2008. PMID: 18471512 Clinical Trial.
-
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.Gastroenterology. 2008 May;134(5):1360-8. doi: 10.1053/j.gastro.2008.02.014. Epub 2008 Feb 13. Gastroenterology. 2008. PMID: 18471513 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources